Navigation Links
Max Institute of Minimal Access, Metabolic & Bariatric Surgery Accredited as an International Centre of Excellence for Minimal Invasive Surgery
Date:6/17/2011

RESEARCH TRIANGLE PARK, N.C., June 17, 2011 /PRNewswire/ -- Max Neeman International, leading Indian CRO, is part of the prestigious Max Group whose sister-company, Max Healthcare recently had one of 12 hospitals, 'Max Institute of Minimal Access, Metabolic & Bariatric Surgery' accredited as a Center of Excellence (COE) by the Surgical Review Corporation (SRC), USA.  The institute has become the first center in India to receive the accreditation.

(Logo: http://photos.prnewswire.com/prnh/20110105/CL25129LOGO)

The Institute's medical team is comprised of 45 people led by Dr. Pradeep Chowbey. They bring with them an accumulated experience of over 48,000 laparoscopic and bariatric surgeries spanning over two decades. The team has been at the forefront to develop and expand the frontiers of minimal access surgery in the country and beyond.

Dr. Chowbey, was featured in the Limca Book of Records from 2000 - 2009, for having performed the largest series of laparoscopic biliary surgeries (over 50,000). He has also been awarded the first honorary membership by Asia-Pacific Hernia Society and Gulf Cooperation Council Hernia Society.  The medical team is proud of having had the honor of operating on His Holiness, The Dalai Lama and His Excellency, Shri K R Narayanan, the former President of India.

As the clinical research arm of the Max Group, Max Neeman works in collaboration with Max Institute of Minimal Access, Metabolic & Bariatric Surgery to conduct minimally invasive surgery studies across multiple therapeutic areas. This collaboration provides global device and pharmaceutical companies with an integrated service offering by leveraging the combined knowledge and experience of both Max Neeman and Max Healthcare to reaffirm our commitment in setting standards of excellence in all facets of patient care.

About Max Healthcare

With over 930 beds, 12 hospitals, 1500 physicians and 3500 support staff - Max Healthcare is one of a leading chain of hospitals in India. Its state of the art infrastructure, over 275 ICU beds and most advanced technologies makes it one of the best hospitals in India. http://www.maxhealthcare.in

About Max Neeman International

Max Neeman International is a leading CRO in India. Our specialty is that we offer services for the successful conduct of Phase II-IV clinical and device trials for small and mid-sized Pharmaceutical, Biotechnology, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. Operational since 2001, Max Neeman is an ISO 9001:2008 certified CRO for Monitoring, Site Management and Data Management Services. The company is presently active in 175 sites across 31 cities with 6 regional offices.  Contact Donald Swankie, Vice President USA at 919.424.3345 / Donald.swankie@neeman-medical.com.

Max Institute of Minimal Access, Metabolic & Bariatric Surgery, Max Healthcare, New Delhi, India is the first of its kind in the subcontinent and globally recognized to be a center of excellence in endosurgery. The Institute is comprised of surgeons who specialize in various areas and are dedicated to performing surgical procedures with a special emphasis on utilization of minimal access techniques (Laparoscopy Surgery), so that patients reap the benefits of faster recovery, lesser post-operative pain and minimal post-surgical complications.


'/>"/>
SOURCE Max Neeman International
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. David H. Murdock Research Institute Assumes Control of the Immune Tolerance Institute and Establishes a State of the Art Human Immune Monitoring Laboratory for Biomarker Discovery and Development
2. Arteriocyte and the U.S. Army Institute of Surgical Research (USAISR) Sign a CRADA to Speed Development of Cellular Therapies for Orthopaedic Trauma
3. Ontario Institute for Cancer Research Announces Spin Off Companies Developing Promising Anticancer Technologies
4. Ludwig Institute for Cancer Research and Polaris Group Form Collaboration to Expand Development of Polaris Novel Cancer Drug, ADI-PEG 20
5. Northwest Biotherapeutics and the Fraunhofer Institute for Cell Therapy and Immunology are Partnering for Clinical Trials and Compassionate Use Cases in Europe
6. Larta Institute Receives Award for National Institutes of Health Commercialization Assistance Program at 2011 Acquisition, Grants, and Small Business Symposium
7. Van Andel Institute Earns Highest "Green Building" Award
8. LifeNet Health Breaks Ground on New Institute of Regenerative Medicine
9. The Wound Institute® to Feature Educational Forum on Dynamic Reciprocity During the Symposium on Advanced Wound Care and the Wound Healing Society Annual Meeting
10. MabVax Therapeutics Receives $1.8 Million in a Phase 2 Small Business Innovation Research Program Award From the National Cancer Institute
11. IBM and The Institute of Bioengineering and Nanotechnology Find Breakthrough for MRSA Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , February 4, 2016 - New FDA action ... - New FDA action date of July 22, ... July 22, 2016   - ... in the past decade indicated for the treatment of signs and symptoms of ... has the potential to be the only product approved in the U.S. in ...
(Date:2/4/2016)... -- Beike Biotechnology, the Shenzhen ... in late 2015 to mark their successful combined efforts ... --> --> The signing, ... Therapy" was hosted by the Shenzhen Cell Bank and ... Beike Biotechnology Co., Ltd. Shenzhen,s ...
(Date:2/4/2016)... 2016 ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ... commercialization of targeted antiviral therapies, announced today that it ... to be held February 8-9, 2016, at the Waldorf ... Growth & Healthcare Conference, taking place in ... James Sapirstein , Chief Executive Officer of ContraVir, ...
(Date:2/4/2016)... 2016 Strasbourg, France , ... --> Strasbourg, France , to the US ... is pleased to announce that it acted as an advisor ... in Strasbourg, France , to the US ... --> Transgene (Euronext: TNG), a member of ...
Breaking Biology Technology:
(Date:2/2/2016)... YORK , Feb. 2, 2016 ... of the bioinformatic market by reviewing the recent ... enabled tools that drive the field forward. Includes ... to: Identify the challenges and opportunities that ... providers and software solution developers, as well as ...
(Date:2/2/2016)... Feb. 2, 2016  Based on its recent ... Sullivan recognizes US-based Intelligent Retinal Imaging Systems (IRIS) ... Award for New Product Innovation. IRIS, a prominent ... North America , is poised to set ... diabetic retinopathy market. The IRIS technology presents superior ...
(Date:1/28/2016)... Synaptics (NASDAQ: SYNA ), a leading developer of ... ended December 31, 2015. --> ... increased 2 percent compared to the comparable quarter last year to ... was $35.0 million, or $0.93 per diluted share. ... first quarter of fiscal 2016 grew 9 percent over the prior ...
Breaking Biology News(10 mins):